ClinConnect ClinConnect Logo
Search / Trial NCT03690271

Study PIEB vs PIEB: the Dose is it Variable According to the Patients

Launched by RENNES UNIVERSITY HOSPITAL · Sep 27, 2018

Trial Information

Current as of June 06, 2025

Completed

Keywords

ClinConnect Summary

In a PIEB, the concentration of local anesthetics administered is standardized in the services according to the recommendations. What is left to the judgement of the clinician, taking care of the patient during the work, is the administered dose. This often varies according to clinician deductions that take notice of height, weight, previous pregnancies In the CHU of Rennes, three dosages are used in common practice. The objective by comparing these three dosages is to show if there is a significant difference between the groups.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patient over 18 years old.
  • Pregnant patient, during labor, live fetus, for whom a PIEB is desired / programmed.
  • Patient not objecting to their participation in the study.
  • Exclusion Criteria:
  • Hemostasis disorder contraindicated the epidural
  • Eclampsia
  • Caesarean section straightaway
  • Patient under legal protection (guardianship, curatorship, safeguard of justice).

About Rennes University Hospital

Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.

Locations

Rennes, , France

Patients applied

0 patients applied

Trial Officials

Eric WODEY, MD, PHD

Principal Investigator

Rennes University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials